Previous 10 | Next 10 |
2023-11-10 02:53:35 ET Japan ( NKY:IND ) -0.24% . China ( SHCOMP ) -0.47%. China's vehicle sales continue thrive, New Energy Vehicles (NEV) sales rocketing by 33.5%. October vehicle sales were up 13.8% y/y (from September's +9.5%). Hong Kong&...
cTTP is an Ultra-rare Blood Clotting Disorder Associated with Life-Threatening Acute Events and Debilitating Chronic Symptoms Takeda Continues 70-plus Year Legacy of Driving Innovation for the Rare Hematology Community Takeda ( TSE:4502/NYSE:TAK ) tod...
2023-11-09 07:21:50 ET More on HUTCHMED, Takeda, etc. Takeda Pharmaceutical Company Limited (TAK) Q2 2023 Earnings Call Transcript Takeda: Why I'm Staying Bearish On This Generic Drug Dividend Play Hutchmed: Progressing, But We Would Like More Clarity On Profit Margi...
2023-11-09 03:10:08 ET Japan ( NKY:IND ) +1.49% . Japan's current account surplus surged to JPY 2,726.3 billion in September 2023 from JPY 853.08 billion in the same month a year earlier but less than market estimates of a gain of JPY 3,000.8 billion. The gauge for Japa...
− FRUZAQLA is the First Targeted Therapy Approved for Metastatic Colorectal Cancer (mCRC) Regardless of Biomarker Status or Prior Types of Therapies in More Than a Decade − FRUZAQLA Plus Best Supportive Care Demonstrated Significant Improvements in Overall Survival, ...
2023-11-08 03:12:05 ET Japan ( NKY:IND ) -0.33% . The Reuters Tankan sentiment index for manufacturers in Japan rose to +6 in November 2023 from +4 in October, showing an improvement in business confidence for the first time since August. Reserve assets in Japan rose sl...
2023-11-07 16:00:06 ET There are very good reasons that stocks generally gain in value after a company receives %OrphanDrug designation (ODD). A study published in Orphanet Journal of Rare Diseases showed that the average stock price of a company increased by 3.36% after the announc...
− The Study Met Its Primary Endpoint with 53.3% and 54.2% of Patients Treated With TAK-279 (15 mg and 30 mg Respectively) Achieving At Least an ACR 20 Response Compared to 29.2% in the Placebo Group at Week 12 (p = 0.002) 1 − TAK-279 Demonstrated Improvem...
2023-11-07 03:10:18 ET Japan ( NKY:IND ) -1.34% . Japan data - September Household Spending -2.8% y/y (vs. expected -2.7%). Japan data - September Labor Cash Earnings +1.2% y/y (expected +1.0%). China ( SHCOMP ) -0.04%. China October exports -6.4% ...
2023-11-05 12:17:29 ET Summary The UST yield curve has steepened and this could provide an opportunity to buy US banking stocks on weakness in a no-recession scenario. Japan and Eurozone exporters can benefit from a global downturn due to easier central bank policies depreciating ...
News, Short Squeeze, Breakout and More Instantly...
Takeda Pharmaceutical Company Limited American Depositary Shares Company Name:
TAK Stock Symbol:
NYSE Market:
Takeda Pharmaceutical Company Limited American Depositary Shares Website:
2024-07-04 20:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting and at the Audit and Supervisory Committee meeting, following the 148th Ordinary Meeting of Shareholders, held in Osaka today. Takeda's Board of Directors has 11 members servi...
LIVTENCITY Is the First and Only Post-Transplant Anti-CMV Treatment Approved in Japan That Targets/Inhibits UL97 Protein Kinase 1 CMV Is One of the Most Common and Serious Post-transplant Infections and Can Lead to Secondary Infections and Serious Consequences, Including Loss of Trans...